Bioneer Corporation (KOSDAQ:064550)
10,850
-50 (-0.46%)
Apr 29, 2026, 10:30 AM KST
Bioneer Revenue
In the year 2025, Bioneer had annual revenue of 330.11B KRW with 12.29% growth. Bioneer had revenue of 79.85B in the quarter ending December 31, 2025, with 13.37% growth.
Revenue
330.11B
Revenue Growth
+12.29%
P/S Ratio
0.85
Revenue / Employee
899.48M
Employees
367
Market Cap
281.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 330.11B | 36.14B | 12.29% |
| Dec 31, 2024 | 293.98B | 30.74B | 11.68% |
| Dec 31, 2023 | 263.24B | 44.84B | 20.53% |
| Dec 31, 2022 | 218.39B | -5.35B | -2.39% |
| Dec 31, 2021 | 223.74B | 16.76B | 8.10% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EASY BIO,Inc. | 476.94B |
| JETEMA, | 76.90B |
| Genexine | 5.81B |
| HLB Therapeutics | 69.56B |
| GC Cell | 165.52B |
| BINEX | 168.47B |
| Anterogen.Co.,Ltd. | 7.54B |
| Helixmith | 2.60B |